Vitamin D has no impact on outcomes after HSCT in children-A retrospective study

Rajinder P S Bajwa1, Kimberly Taylor1, Amanda Hoyt1

  • 1Division of Pediatric Hem/Onc/BMT, Nationwide Children's Hospital, Columbus, OH, USA.

Insights

Vitamin D deficiency (VDD) or insufficiency (VDI) did not impact outcomes in pediatric patients undergoing allogeneic hematopoietic stem cell transplant (HSCT). Further multicenter studies are needed to confirm these findings in pediatric HSCT. Keywords: Vitamin D, HSCT, pediatric, outcomes.

Area of Science:

  • Immunology
  • Pediatric Hematology/Oncology
  • Endocrinology

Background:

  • Vitamin D plays a crucial role in bone metabolism and immune function.
  • Low vitamin D levels may negatively affect immune-mediated processes.
  • Pediatric studies on vitamin D and allogeneic HSCT are predominantly single-center.

Purpose of the Study:

  • To investigate the association between vitamin D levels and outcomes in pediatric patients undergoing allogeneic HSCT.
  • To compare transplant characteristics and outcomes in children with vitamin D deficiency/insufficiency versus normal levels.

Main Methods:

  • Retrospective analysis of 233 pediatric patients undergoing allogeneic HSCT across 5 US centers.
  • Vitamin D levels categorized as deficiency (<20 ng/ml) or insufficiency (21-30 ng/ml).
  • Comparison of engraftment, infections, hospital stay, graft failure, GvHD, survival, and relapse rates.

Main Results:

  • Mean vitamin D levels were suggestive of insufficiency pre-HSCT and early post-HSCT, normalizing later.
  • No statistically significant differences were observed in neutrophil/platelet engraftment between groups.
  • Infections, GvHD, survival, and relapse rates were similar across vitamin D level groups.

Conclusions:

  • Vitamin D insufficiency or deficiency does not appear to affect key transplant variables in pediatric allogeneic HSCT.
  • Larger, multicenter prospective studies are warranted to further elucidate the role of vitamin D in HSCT outcomes.

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
6.9K
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.7K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
602
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
63